Literature DB >> 19500270

Micronuclear and sister chromatid exchange analyses in peripheral lymphocytes of patients with oral lichen planus--a pilot study.

S Ergun1, S Warnakulasuriya, N Duman, A Saruhanoğlu, B Sevinç, S Oztürk, S Ozel, K Cefle, S Palanduz, H Tanyeri.   

Abstract

OBJECTIVE: The purpose of this study was to determine the genetic instability of peripheral blood lymphocytes from patients diagnosed with oral lichen planus (OLP) by investigation of frequencies of micronuclei (MN) and sister chromatid exchange (SCE).
MATERIALS AND METHODS: A total of 22 newly diagnosed and untreated patients with OLP of same severity scores and twenty healthy controls participated in this study. They were all non-smokers with no previous history or family history of cancer. The periodontal status, flow rate and buffering capacity of whole mouth saliva were recorded. SCE and MN analyses were performed on peripheral blood lymphocytes of OLP patients and healthy controls.
RESULTS: The frequencies of MN (50.00 +/- 22.36) and SCE (6.89 +/- 1.48) in OLP patients were found to be significantly elevated compared with that in normal individuals (25.20 +/- 9.52 and 5.93 +/- 1.31; z = 3.946, P = 0.0001; z = 2.346, P = 0.019). There were no significant differences in the MN frequency and SCE between the two subgroups with reticular or erosive types of OLP.
CONCLUSION: These pilot data indicate an increased genomic instability in peripheral blood lymphocytes of a cohort of Turkish patients diagnosed with oral lichen planus as compared with that of healthy individuals. As patients with OLP may have an increased or potential risk for oral malignancy, these assays could be used in translational research to monitor beneficial effects of interventions and long-term prognosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19500270     DOI: 10.1111/j.1601-0825.2009.01576.x

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  1 in total

1.  Cervical metastases behavior of T1-2 squamous cell cancer of the oral mucosa.

Authors:  Keyvan Sagheb; Sebastian Blatt; Roman-Kia Rahimi-Nedjat; Simone Eigenbrodt; Bilal Al-Nawas; Christian Walter
Journal:  Clin Oral Investig       Date:  2016-05-16       Impact factor: 3.573

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.